NV5 will host a conference call to discuss its full year 2024 financial results at 4:30 p.m. (Eastern Time) on February 20, 2025. The accompanying presentation for the call is available by visiting ...

Adjusted Ebitda can be a useful tool, but it should not be relied on as the sole indicator of a company’s financial health.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced its fourth-quarter and full-year 2024 financial and operating results. In the quarter, the company generated over $2.0 billion in cash from ...

Lofty U.S. stock valuations call for a renewed focus on risk assessment and portfolio diversification. Read more here.

The company recently announced it has achieved its near-term debt repayment target of $4.5 billion in the fourth quarter of ...

We recently published a list of 10 Stocks Insiders Spent The Most Money On Recently. In this article, we are going to take a look at where Immunovant, Inc.